Merck rises; WSJ reports co to split cancer business ahead of Keytruda patent loss
ReutersFeb 23, 2026 11:34 AM
Shares of drugmaker Merck MRK.N rise 1.41% to $123.98 premarket
MRK is creating a separate cancer business as it prepares for its top-selling cancer drug Keytruda to lose U.S. patent protection in 2028 - the Wall Street Journal
MRK's Keytruda brings in nearly half of Merck's sales and could face cheaper copies after the patent expires, WSJ reports
A second unit will house vaccines, diabetes drugs and new launches such as lung-disease therapy Winrevair - WSJ
WSJ reports Merck is planning over 20 drug launches and reorganizing leadership to support future products
Shares rose ~6% in 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
International Copper Prices Rise for 7 Straight Months; Will Bull Market Continue in 2026?
TradingKey - As the "king of industrial metals," every fluctuation in international copper prices impacts the nerves of global investors. In early 2026, international copper prices continued to rise, extending the upward trend from 2025 and reaching a new high above $14,500, marking seven consecutive months of gains. Meanwhile, London Metal Exchange (LME) copper prices have climbed from $7,800 per tonne in July 2025 to over $9,000 per tonne today.TradingKey
6 hours ago
How Bitcoin Miners Are Scaling Revenue Through AI Data Center Integration
Discover how Bitcoin miners like Core Scientific and IREN are scaling revenue by pivoting to AI data centers. Explore 2026 hashprice trends, ASIC-to-GPU retrofitting, and the "hashrate-to-HPC" revolution.TradingKey
Sun, Feb 22
Stock Market Crash 2026: What Fed Signals and Economic Data Mean for Investors
TradingKey - The possibility of a stock market crash occurring in 2026 is becoming increasingly likely as investor sentiment continues to decline.TradingKey
Thu, Feb 19
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.TradingKey
Thu, Feb 19
